3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
15
Neoplasms
11
Breast Neoplasms
11
Prostatic Neoplasms
7
Obesity
5
Head and Neck Neoplasms
5
Signs and Symptoms
3
Sarcopenia
3
Polycystic Ovary Syndrome
3
Lung Neoplasms
3
Diabetes Mellitus, Type 2
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Pharyngeal Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Laryngeal Neoplasms
2
Fatigue
2
Diabetes Mellitus
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Stroke
1
Squamous Cell Carcinoma of Head and Neck
1
Sedentary Behavior
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Interventions
Fluorouracil
128
Leucovorin
120
Oxaliplatin
101
Irinotecan
89
Bevacizumab
55
Cetuximab
44
Capecitabine
40
Folfox protocol
29
Panitumumab
22
Colonoscopy
17
Chemotherapy, Adjuvant
16
Floxuridine
15
Early Intervention, Educational
15
Erlotinib Hydrochloride
13
Surveys and Questionnaires
11
IFL protocol
11
Counseling
11
Immunohistochemistry
10
Gemcitabine
10
Celecoxib
10
Psychiatric Rehabilitation
9
Methods
8
Magnetic Resonance Spectroscopy
8
Gene Expression Profiling
8
Exercise
8
Dexamethasone
8
sargramostim
7
Sorafenib
7
Radiotherapy
7
Nivolumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Neoplasms
×
Resistance Training
×
Clear all
NCT03291951
2022-07-28
FORCE
Kaiser Permanente
Phase NA
Completed
183 enrolled